GitLab is transitioning from hypergrowth to disciplined scaling, with fundamentals outpacing its current valuation after a 60% stock decline. GTLB's platform consolidation pitch is resonating: 13% of 10,000+ customers pay $100,000+ annually, and DBNRR remains robust at 119%. Revenue growth exceeds 25%, margins are expanding, and free cash flow is positive, yet the market is not rewarding these improvements.

GitLab Inc. (NASDAQ: GTLB - Get Free Report) shares hit a new 52-week low during mid-day trading on Tuesday after Mizuho lowered their price target on the stock from $47.00 to $37.00. Mizuho currently has a neutral rating on the stock. GitLab traded as low as $28.29 and last traded at $27.9690, with a volume of

SAN FRANCISCO--(BUSINESS WIRE)--All Remote - GitLab Inc., (NASDAQ: GTLB), the intelligent orchestration platform for DevSecOps, today announced that it will report its financial results for the fourth quarter and its full fiscal year 2026, which ended January 31, 2026, after U.S. markets close on Tuesday, March 3, 2026. Management will host a conference call and webcast on the same day to discuss the company's financial results at 4:30 p.m. ET / 1:30 p.m. PT. GitLab Fourth Quarter and Full Fisc.

GTLB stock slides as competition, public sector delays, and valuation concerns overshadow its AI-driven DevSecOps growth story.

Cathie Wood is once again leaning into momentum. ARK Invest added to several high-profile names on Feb. 13, buying into stocks that had just rallied on earnings

In the fourth quarter of 2025, the Baron Discovery Fund returned 0.19% (Institutional Shares), trailing the Russell 2000 Growth Index by 1.03%. In these periods, low quality (high debt and poor profitability) and short-term price momentum-oriented stocks outperformed. Exact Sciences Corporation received a buyout offer in the fourth quarter by Abbott Laboratories (ABT) for a price of $105 in cash.

Caprock Group LLC acquired a new stake in shares of GitLab Inc. (NASDAQ: GTLB) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 25,194 shares of the company's stock, valued at approximately $1,210,000. Several other institutional investors and hedge

We invest in secular growth and innovative businesses across all market capitalizations, with the bulk of the portfolio landing in the large-cap zone. We recently initiated a position in Axon Enterprise. We exited our successful investment in Exact Sciences Corporation after Abbott Laboratories announced it was acquiring the company for approximately $23 billion in cash.

GitLab Inc. (GTLB) Discusses the Role of Agentic AI in Transforming Software Development Workflows Transcript

SAN FRANCISCO--(BUSINESS WIRE)--All Remote - GitLab Inc., the intelligent orchestration platform for DevSecOps, today hosted GitLab Transcend, an exclusive virtual event for technology leaders highlighting the true potential of agentic AI for software delivery. GitLab Transcend showcased how software teams are orchestrating AI agents across the entire development lifecycle. Attendees learned how this approach helps accelerate innovation by automating hundreds of routine tasks that traditionally.